These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9533072)

  • 1. Significance of a tetracycline and Pepto-Bismol interaction in the management of Helicobacter pylori-induced peptic ulcer disease.
    Tkach CL; Ariano RE
    Ann Pharmacother; 1998 Mar; 32(3):387. PubMed ID: 9533072
    [No Abstract]   [Full Text] [Related]  

  • 2. Helicobacter pylori and peptic ulcer disease. Reexamining the therapeutic approach.
    Fedotin MS
    Postgrad Med; 1993 Sep; 94(3):38-40, 43-5. PubMed ID: 8361941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six months' experience with a pharmacist-run Helicobacter pylori treatment clinic.
    Patchin GM; Wieland KA; Carmichael JM
    Am J Health Syst Pharm; 1996 Sep; 53(17):2081-2. PubMed ID: 8991624
    [No Abstract]   [Full Text] [Related]  

  • 4. Treating peptic ulcer: an ongoing challenge.
    Cohen MH
    J Am Osteopath Assoc; 1995 Apr; 95(4):239-41. PubMed ID: 7744624
    [No Abstract]   [Full Text] [Related]  

  • 5. Helicobacter pylori: consensus reached: peptic ulcer is on the way to becoming an historic disease.
    Peura DA; Graham DY
    Am J Gastroenterol; 1994 Aug; 89(8):1137-9. PubMed ID: 8053422
    [No Abstract]   [Full Text] [Related]  

  • 6. Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection.
    al-Assi MT; Ramirez FC; Lew GM; Genta RM; Graham DY
    Am J Gastroenterol; 1994 Aug; 89(8):1203-5. PubMed ID: 8053435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease.
    Graham DY; Hepps KS; Ramirez FC; Lew GM; Saeed ZA
    Scand J Gastroenterol; 1993 Nov; 28(11):939-42. PubMed ID: 8284627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eradication of Helicobacter pylori reduces gastric and duodenal ulcer recurrence.
    Laine L
    Gastroenterology; 1992 Nov; 103(5):1695-6. PubMed ID: 1426890
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification and eradication of Helicobacter pylori in an isolated patient population.
    Myers D
    Mil Med; 1997 Jul; 162(7):507-9. PubMed ID: 9232984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing the eradication of Helicobacter pylori with triple therapy.
    Graham DY; Lew GM; Malaty HM; Evans DG; Evans DJ; Klein PD; Alpert LC; Genta RM
    Gastroenterology; 1992 Feb; 102(2):493-6. PubMed ID: 1732120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of peptic ulcer and gastritis associated with Helicobacter pylori].
    López-Brea M; Alarcón T
    Enferm Infecc Microbiol Clin; 1995; 13(7):422-8. PubMed ID: 8519820
    [No Abstract]   [Full Text] [Related]  

  • 12. Helicobacter pylori therapy: effect on peptic ulcer disease.
    Axon AT
    J Gastroenterol Hepatol; 1991; 6(2):131-7. PubMed ID: 1912418
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment strategies for Helicobacter pylori infection.
    Damianos AJ; McGarrity TJ
    Am Fam Physician; 1997 Jun; 55(8):2765-74, 2784-6. PubMed ID: 9191460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HELIDAC therapy (bismuth subsalicylate/metronidazole/tetracycline hydrochloride).
    Claussen DW
    Gastroenterol Nurs; 1997; 20(5):188-9. PubMed ID: 9384064
    [No Abstract]   [Full Text] [Related]  

  • 15. H. pylori and ulcers.
    McGuffey EC
    Am Pharm; 1994 Jul; NS34(7):21. PubMed ID: 8085532
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic approaches to recurrent peptic ulcer disease.
    Cave DR
    Hosp Pract (Off Ed); 1992 Sep; 27(9A):33-40, 43, 47-9. PubMed ID: 1522168
    [No Abstract]   [Full Text] [Related]  

  • 18. Azithromycin triple therapy for Helicobacter pylori infection: azithromycin, tetracycline, and bismuth.
    al-Assi MT; Genta RM; Karttunen TJ; Cole RA; Graham DY
    Am J Gastroenterol; 1995 Mar; 90(3):403-5. PubMed ID: 7872278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bismuth subcitrate/metronidazole/ tetracycline--Axcan Pharma. Bismuth triple therapy--Axcan Pharma, Helicide.
    Drugs R D; 2002; 3(6):402-4. PubMed ID: 12516945
    [No Abstract]   [Full Text] [Related]  

  • 20. [Resolution of an autoimmune thrombocytopenic purpura after eradicating treatment of Helicobacter pylori].
    García Pérez A; Valverde de La Osa J; Giménez Samper M; Alonso García I
    Sangre (Barc); 1999 Oct; 44(5):387-8. PubMed ID: 10618919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.